Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals
| dc.contributor.author | Hoşo?lu, S. | |
| dc.contributor.author | Gundes, S. | |
| dc.contributor.author | Kolayli, F. | |
| dc.contributor.author | Karadenizli, A. | |
| dc.contributor.author | Demirda?, K. | |
| dc.contributor.author | Gunaydin, M. | |
| dc.contributor.author | Ucmak, H. | |
| dc.date.accessioned | 2026-08-12T16:10:33Z | |
| dc.date.issued | 2007 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Purpose: To study the prevalence of TEM-, SHV- and GES-type ?-lactamases among Escherichia coli and Klebsiella pneumoniae strains having ceftazidime MICs higher than 2 mg/L. Methods: A total of 63 E. coli and 41 K. pneumoniae isolated from five different university hospitals were studied for the existence of TEM-, SHV- and GES-type ?-lactamases. Susceptibility tests were carried out according to the criteria of National Committee for Clinical Laboratory Standards. MICs were obtained by agar dilution method. Existence of extended-spectrum ?-lactamases (ESBLs) were assessed by double-disc synergy test (DDST). Existence of the above-mentioned ?-lactamase genes were studied both by PCR with specific oligonucleotide primers and isoelectric focusing methods. Results: None of the isolates were carbapenem-resistant. DDSTs were positive in 50 (79.3%) and 33 (80.5%) of E. coli and K. pneumoniae , respectively. TEM gene was detected in 41 (65.1%) and 19 (46.3%), whereas SHV gene in 18 (28.6%) and 20 (48.8%) of E. coli and K. pneumoniae strains, respectively. GES genes were not detected. Conclusions: TEM and SHV genes are highly prevalent among ESBL-producing E. coli and K. pneumoniae , whereas GES-type ESBLs are absent and found not to be responsible of ceftazidime resistance in Turkish hospitals. | |
| dc.identifier.doi | 10.1016/s0255-0857(21)02048-x | |
| dc.identifier.endpage | 350 | |
| dc.identifier.issn | 0255-0857 | |
| dc.identifier.issue | 4 | |
| dc.identifier.pmid | 18087082 | |
| dc.identifier.scopus | 2-s2.0-37549009519 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 346 | |
| dc.identifier.uri | https://doi.org/10.1016/s0255-0857(21)02048-x | |
| dc.identifier.uri | https://hdl.handle.net/11508/42005 | |
| dc.identifier.volume | 25 | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Medknow Publications and Media Pvt. Ltd | |
| dc.relation.ispartof | Indian Journal of Medical Microbiology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_Scopus_20260511 | |
| dc.subject | Ceftazidime-resistant; E. coli; ESBL; GES; Klebsiella; SHV; TEM | |
| dc.title | Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals | |
| dc.type | Article |







